Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. ORIC
  6. >
  7. Forecast
stocks logo

ORIC Stock Price Prediction

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)

Should I Buy Oric Pharmaceuticals Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ORIC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

ORIC stock price ended at $5.14 on Monday, after rising 8.67%

The Oric Pharmaceuticals Inc stock price increased by 8.67% on the last trading day (19 May 2025), rising from 4.8 to 5.14. Throughout the last trading session, the stock experienced a fluctuation of 11.37% , ranging from a day low of $4.66 to a day high of 5.19. The price has declined in 7 of the last 10 days, resulting in a total change of -9.82% during this period. On the last day, trading volume increase by 140.76K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 771.39K  shares were traded, amounting to approximately 3.81M.

ORIC Technical Signals

ORIC(Oric Pharmaceuticals Inc Corp) has 3 buy signals and 3 sell signals now. The current trend is uptrend starting from 2025-05-07. The total price change during this trend is +0.64%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of ORIC over the last 5 trading days is 2.39M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.

ORIC Moving Average Analysis

Oric Pharmaceuticals Inc's overall moving average trend leans more bearish as of Tuesday, May 20, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $5.95608, and $6.4565. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $4.336919999999999, and $3.836499999999999. A break-down below any of these levels will issue sell signals.

ORIC Short Selling Analysis

The short sale ratio of Oric Pharmaceuticals Inc(ORIC) as of 12 May 2025 is 16.52%, dropping from last trading day. With decreasing price from 5.08 to 5.41. The short sell activity indicate that short sellers may be experiencing short cover.

Technical Signal

Technical Signals Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
3

Moving Average

Swing

up ImagePositive

Stock Price Above SMA_5

Short Term

down ImageNegative

SMA_5 Below SMA_20

Mid Term

down ImageNegative

SMA_20 Below SMA_60

Long Term

down ImageNegative

SMA_60 Below SMA_200

Short Selling

Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Stochastic Oscillator %K (14, 3, 3)

STOCHk_14_3_3 < 20

18.72

Bullish

Commodity Channel Index (20 days, 0.015 constant)

CCI_20_0.015 < -100

-124.862

Bullish

Williams %R (14 days)

WILLR_14 < -80

-84.783

Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 < 0

-0.0568

Bearish

Momentum (10 days)

MOM_10 < 0

-0.94

Bearish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 < 0

-0.218

Bearish

ORIC Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Oric Pharmaceuticals Inc(ORIC), our algorithm predicts ORIC's 1-month price at $5.71, with an 12.34%upwardshift. Using a similarity score up to 92.99%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Oric Pharmaceuticals Inc (ORIC.O) stock, as of Sunday, May 11, 2025 , forecasts a 12.34% change over the next month, based on its high correlation with IRON.O stock patterns. The similarity between their price movements over the analyzed periods is 92.99%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
stocks logo

ORIC

No Data
stocks logo

IRON

Up: 12.34%Similarity: 92.99%

Name

Similarity

Up/Down

stocks logo

IRON.O

92.99%

+12.34%

stocks logo

WVE.O

92.21%

-1.90%

stocks logo

FRO.N

90.53%

-12.71%

ORIC Seasonality Analysis

Based on ORIC's historical stock price data across all years, the probability of a positive return in May is40.00%, suggesting it maynotbe an ideal month to invest in ORIC. In contrast,Novemberoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Oric Pharmaceuticals Inc (ORIC.O) stock in November has the highest probability of a positive return (80.00%), while September has the lowest probability (0.00%).

Performance Seasonality

The chart shows Oric Pharmaceuticals Inc. (ORIC)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.

People Also Watch

FAQ

arrow icon

Should I buy Oric Pharmaceuticals Inc (ORIC.O) stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ORIC has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
arrow icon

Which months have the highest win rate for buying Oric Pharmaceuticals Inc (ORIC.O) stock in a year?

The radar chart shows that buying Oric Pharmaceuticals Inc (ORIC.O) stock in November has the highest probability of a positive return (80.00%), while September has the lowest probability (0.00%).

arrow icon

How has Oric Pharmaceuticals Inc. (ORIC)'s stock price performed over the past three years?

ORIC's stock price rose by 53.59% in 2023,decreased by -11.71% in 2024, and went down by 37.77% in 2025.

arrow icon

Which bull technical signals does ORIC have?

Bullish technical signals of ORIC include: STOCHk_14_3_3 < 20, CCI_20_0.015 < -100, WILLR_14 < -80.

arrow icon

Which bearish technical signals does ORIC have?

Bearish technical signals of ORIC include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0.

arrow icon

Is ORIC a buy based on overall technical signals summary?

ORIC has 3 buy signals and 3 sell signals now. Overall the technical rating for ORIC is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of ORIC.

arrow icon

What is the trend of Oric Pharmaceuticals Inc (ORIC)'s moving average?

Oric Pharmaceuticals Inc's overall moving average trend leans more bearish as of May 20 2025, with 3 negative signals and 1 positive signal.

arrow icon

What is price prediction for ORIC stock next month?

The price prediction chart for Oric Pharmaceuticals Inc (ORIC.O) stock, as of May 11 2025, forecasts a 12.34% change over the next month, based on its high correlation with IRON stock patterns. The similarity between their price movements over the analyzed periods is 92.99%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

arrow icon

What is price prediction 2025 for ORIC Stock?

### **Price Prediction for ORIC Stock in 2025** ORIC Pharmaceuticals, Inc. (ORIC) is expected to trade between **$18 and $22** by the end of 2025. The stock is currently undervalued, with positive trial data and analyst upgrades driving optimism. The $21 price target from HC Wainwright supports this bullish outlook.

arrow icon

What is price prediction 2030 for ORIC Stock?

### **Price Prediction for ORIC Stock by 2030** ORIC Pharmaceuticals (ORIC) is a clinical-stage oncology company focused on developing treatments for cancer. Based on current data and analysis, here is a concise price prediction for ORIC stock by 2030: 1. **Bullish Scenario**: ORIC stock could reach **$35-$45** by 2030 if its lead candidates, ORIC-944 and ORIC-114, achieve successful Phase 3 trial results and gain FDA approval, capturing significant market share in targeted cancer therapies. 2. **Base Scenario**: A more moderate price target of **$25-$35** is possible if the company demonstrates incremental progress in its pipeline, with one drug achieving commercial success and the other showing promise but requiring additional development. 3. **Bearish Scenario**: The stock could trade in the **$10-$20 range** if clinical trials face setbacks or competition intensifies in the oncology space. **Key Drivers**: - **Pipeline Success**: ORIC-944 and ORIC-114 are in critical stages of development, with Phase 3 trials expected to start in 2026. - **Market Opportunity**: Targeted therapies in oncology are a high-growth market, and ORIC's focus on resistance mechanisms positions it well. - **Financial Health**: The company has a cash runway into 2027, providing stability for development.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free